Alicia Arredondo Eve

Dr. Alicia Arredondo Eve

Food Science and Human Nutrition, University of Illinois Urbana-Champaign, Urbana, Illinois, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
ETElif Tunc
Elif Tunc
Alicia Arredondo EveAlicia Arredondo Eve
Alicia Arredondo Eve
ZMZeynep Madak-Erdogan
Zeynep Madak-Erdogan

20 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Alicia Arredondo EveAlicia Arredondo Eve
Alicia Arredondo Eve
XLXiaoji Liu
Xiaoji Liu
YWYanling Wang
Yanling Wang
MMMichael Miller
Michael Miller
Elizabeth H JefferyElizabeth H Jeffery
Elizabeth H Jeffery
ZMZeynep Madak-Erdogan
Zeynep Madak-Erdogan
Diet and lifestyle choices contribute to obesity and liver disease. Broccoli, a brassica vegetable, may mitigate negative effects of both diet and lifestyle. Currently, there are no clinically relevant, established molecular biomarkers that reflect variability in human absorption of brassica bioactives, which may be the cause of variability/inconsistencies in health benefits in the human population. Here, we focused on the plasma metabolite profile and composition of the gut microbiome in rats, a relatively homogenous population in terms of gut microbiota, genetics, sex and diet, to determine if changes in the plasma metabolite profiles caused by dietary broccoli relate to molecular changes in liver. Our aim was to identify plasma indicators that reflect how liver health is impacted by dietary broccoli. Rats were fed a 10% broccoli diet for 14 days. We examined the plasma metabolite composition by metabolomics analysis using GC–MS and gut microbiota using 16S sequencing after 0, 1, 2, 4, 7, 14 days of broccoli feeding. We identified 25 plasma metabolites that changed with broccoli consumption, including metabolites associated with hepatic glutathione synthesis, and with de novo fatty acid synthesis. Glutamine, stearic acid, and S-methyl-L-cysteine (SMC) relative abundance changes correlated with changes in gut bacteria previously implicated in metabolic disease and with validated increases in expression of hepatic NAD(P)H dehydrogenase [quinone] 1 (NQO1) and nuclear factor (erythroid-derived 2)-like 2 (Nrf2), associated with elevated hepatic glutathione synthesis. Circulating biomarkers following broccoli consumption reflect gut–liver axis health.

23 September 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
QZQIANYING ZUO
QIANYING ZUO
KCKaren L. Chen
Karen L. Chen
Alicia Arredondo EveAlicia Arredondo Eve
Alicia Arredondo Eve
YLYu-Jeh Liu
Yu-Jeh Liu
SKSung Hoon Kim
Sung Hoon Kim
ZMZeynep Madak-Erdogan
Zeynep Madak-Erdogan
About 20–30% of premenopausal women have metabolic syndrome, and the number is almost double in postmenopausal women, and these women have an increased risk of hepatosteatosis. Postmenopausal women with metabolic syndrome are often treated with hormone replacement therapy (HRT), but estrogens in currently available HRTs increase the risk of breast and endometrial cancers and Cardiovascular Disease. Therefore, there is a critical need to find safer alternatives to HRT to improve postmenopausal metabolic health. Pathway preferential estrogen 1 (PaPE-1) is a novel estrogen receptor ligand that has been shown to favorably affect metabolic tissues without adverse effects on reproductive tissues. In this study, we have examined the effects of PaPE-1 on metabolic health, in particular, examining its effects on the liver transcriptome and on plasma metabolites in two different mouse models: diet-induced obesity (DIO) and leptin-deficient (ob/ob) mice. PaPE-1 significantly decreased liver weight and lipid accumulation in both DIO and ob/ob models and lowered the expression of genes associated with fatty acid metabolism and collagen deposition. In addition, PaPE-1 significantly increased the expression of mitochondrial genes, particularly ones associated with the electron transport chain, suggesting an increase in energy expenditure. Integrated pathway analysis using transcriptomics and metabolomics data showed that PaPE-1 treatment lowered inflammation, collagen deposition, and pathways regulating fatty acid metabolism and increased metabolites associated with glutathione metabolism. Overall, our findings support a beneficial metabolic role for PaPE-1 and suggest that PaPE-1 may protect postmenopausal women from fatty liver disease without increasing reproductive cancer risk.

25 May 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
Alicia Arredondo EveAlicia Arredondo Eve
Alicia Arredondo Eve
ETElif Tunc
Elif Tunc
YLYu-Jeh Liu
Yu-Jeh Liu
Saumya AgrawalSaumya Agrawal
Saumya Agrawal
HYHuriye Erbak Yilmaz
Huriye Erbak Yilmaz
ZMZeynep Madak-Erdogan
Zeynep Madak-Erdogan
Coronary microvascular disease (CMD) is a common form of heart disease in postmenopausal women. It is not due to plaque formation but dysfunction of microvessels that feed the heart muscle. The majority of the patients do not receive a proper diagnosis, are discharged prematurely and must go back to the hospital with persistent symptoms. Because of the lack of diagnostic biomarkers, in the current study, we focused on identifying novel circulating biomarkers of CMV that could potentially be used for developing a diagnostic test. We hypothesized that plasma metabolite composition is different for postmenopausal women with no heart disease, CAD, or CMD. A total of 70 postmenopausal women, 26 healthy individuals, 23 individuals with CMD and 21 individuals with CAD were recruited. Their full health screening and tests were completed. Basic cardiac examination, including detailed clinical history, additional disease and prescribed drugs, were noted. Electrocardiograph, transthoracic echocardiography and laboratory analysis were also obtained. Additionally, we performed full metabolite profiling of plasma samples from these individuals using gas chromatography-mass spectrometry (GC–MS) analysis, identified and classified circulating biomarkers using machine learning approaches. Stearic acid and ornithine levels were significantly higher in postmenopausal women with CMD. In contrast, valine levels were higher for women with CAD. Our research identified potential circulating plasma biomarkers of this debilitating heart disease in postmenopausal women, which will have a clinical impact on diagnostic test design in the future.

6 May 2026 in PLOS ONE
Verified
Journal Article
Open access
AGAnne Elizabeth Glassgow
Anne Elizabeth Glassgow
CFClaire Flanigan
Claire Flanigan
AGAnahi A. Gante Gaytan
Anahi A. Gante Gaytan
SKSage Kim
Sage Kim
ASAiman Soliman
Aiman Soliman
ZMZeynep Madak-Erdogan
Zeynep Madak-Erdogan
Maternal mortality and morbidity in the United States remain substantially higher than in other high-income countries. Evidence suggests that exposure to chronic stress and social and environmental adversity contributes to maternal health risk through interconnected biological, psychological, and structural pathways. While these associations are documented, the molecular mechanisms linking adversity to maternal health outcomes remain poorly defined. This protocol describes a five-year, prospective, explanatory sequential mixed-methods cohort study (N = 200) designed to map how multilevel stress exposures influence biological and clinical outcomes among urban postpartum women. The study integrates geocoded neighborhood-level data, longitudinal electronic health records, and comprehensive interviewer-administered surveys assessing trauma, social support, and mental health. To identify the biological pathways of adversity, we employ multi-omics profiling of peripheral blood mononuclear cells—including DNA methylation, chromatin accessibility, and histone modification—alongside inflammatory and steroid hormone assays. Statistical frameworks, including Exposome-Wide Association Studies and spatial mediation modeling, will evaluate the interplay between socio-ecological stressors and molecular signatures during the postpartum period. Findings will advance understanding of the biological embedding of adversity and inform multilevel interventions to improve maternal health outcomes.